NASDAQ:TWST Twist Bioscience - TWST Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. $23.73 -1.58 (-6.24%) (As of 02/6/2023 12:00 AM ET) Add Compare Share Share Today's Range$23.38▼$25.9350-Day Range$21.92▼$30.9052-Week Range$21.78▼$66.15Volume1.86 million shsAverage Volume1.11 million shsMarket Capitalization$1.34 billionP/E RatioN/ADividend YieldN/APrice Target$37.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Twist Bioscience MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside42.6% Upside$33.83 Price TargetShort InterestBearish16.03% of Shares Sold ShortDividend StrengthN/ASustainability-1.42Upright™ Environmental ScoreNews Sentiment0.51Based on 18 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($4.53) to ($3.73) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.35 out of 5 starsMedical Sector214th out of 1,027 stocksBiological Products, Except Diagnostic Industry40th out of 169 stocks 4.3 Analyst's Opinion Consensus RatingTwist Bioscience has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $33.83, Twist Bioscience has a forecasted upside of 42.6% from its current price of $23.73.Amount of Analyst CoverageTwist Bioscience has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted16.03% of the outstanding shares of Twist Bioscience have been sold short.Short Interest Ratio / Days to CoverTwist Bioscience has a short interest ratio ("days to cover") of 7.5.Change versus previous monthShort interest in Twist Bioscience has recently increased by 3.89%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldTwist Bioscience does not currently pay a dividend.Dividend GrowthTwist Bioscience does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTwist Bioscience has received a 65.93% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is false driven by its "Deoxyribonucleic acid (DNA)" and "Monoclonal antibodies for research" products. See details.Environmental SustainabilityThe Environmental Impact score for Twist Bioscience is -1.42. Previous Next 3.1 News and Social Media Coverage News SentimentTwist Bioscience has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Twist Bioscience this week, compared to 2 articles on an average week.Search Interest15 people have searched for TWST on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows6 people have added Twist Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Twist Bioscience insiders have not sold or bought any company stock.Percentage Held by Insiders11.80% of the stock of Twist Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Twist Bioscience are expected to grow in the coming year, from ($4.53) to ($3.73) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Twist Bioscience is -6.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Twist Bioscience is -6.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTwist Bioscience has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Twist Bioscience (NASDAQ:TWST) StockTwist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. Its products include genes, oligo pools, Next Generation Sequencing (NGS), variant libraries, synthetic controls, antibody discovery, and SARS-CoV-2 Tools. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment consists of Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.Read More Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Stock News HeadlinesFebruary 6, 2023 | wsj.comFRIDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the FirmFebruary 6, 2023 | americanbankingnews.comBarclays Cuts Twist Bioscience (NASDAQ:TWST) Price Target to $32.00February 7, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...February 3, 2023 | markets.businessinsider.comTwist Bioscience Corp Q1 Loss decreases, beats estimatesFebruary 3, 2023 | msn.comTwist Bioscience slips after Q1 results as outlook disappointsFebruary 1, 2023 | wsj.comTwist Shareholder NoticeFebruary 1, 2023 | americanbankingnews.comTwist Bioscience (TWST) to Release Quarterly Earnings on FridayJanuary 31, 2023 | finance.yahoo.comThese 2 ‘Oversold’ Stocks Could Be Ready for a Comeback, Say AnalystsFebruary 7, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 31, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) PT Lowered to $37.00January 29, 2023 | americanbankingnews.comTwist Bioscience Co. (NASDAQ:TWST) Given Average Recommendation of "Moderate Buy" by AnalystsJanuary 28, 2023 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Shares Gap Up to $27.98January 27, 2023 | benzinga.comCLASS ACTION UPDATE for AFRM, TWST and ENVX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersJanuary 26, 2023 | wsj.comFINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the FirmJanuary 19, 2023 | finance.yahoo.comTwist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023January 13, 2023 | benzinga.comTwist Bioscience Corporation (TWST) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Twist Bioscience CorporationJanuary 11, 2023 | wsj.comKessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience CorporationJanuary 10, 2023 | finance.yahoo.comTwist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support DiagnosticsJanuary 9, 2023 | benzinga.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Twist Bioscience Corp. (TWST)January 9, 2023 | finance.yahoo.comTwist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research CollaborationJanuary 7, 2023 | apnews.comTwist Bioscience Corporation (TWST) Equity Notice: Robbins LLP Urges Investors with Significant Losses to Contact the FirmJanuary 5, 2023 | wsj.comHAGENS BERMAN Alerts Twist Bioscience (TWST) Investors to Securities Fraud Class Action, Encourages Investors with Losses to Contact Firm's AttorneysJanuary 2, 2023 | apnews.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Twist Bioscience Corporation - TWSTDecember 29, 2022 | benzinga.comTWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud LawsuitDecember 25, 2022 | finance.yahoo.comTwist Bioscience Corporation (NASDAQ:TWST) Q4 2022 Earnings Call TranscriptDecember 22, 2022 | finance.yahoo.comIs Twist Bioscience Corporation (TWST) a Worthy Long-Term Investment?December 20, 2022 | wsj.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Company Calendar Last Earnings2/03/2023Today2/06/2023Next Earnings (Estimated)5/04/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TWST CUSIPN/A CIK1581280 Webwww.twistbioscience.com Phone(800) 719-0671FaxN/AEmployees652Year FoundedN/APrice Target and Rating Average Stock Price Forecast$33.83 High Stock Price Forecast$43.00 Low Stock Price Forecast$29.00 Forecasted Upside/Downside+57.3%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.86) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-217,860,000.00 Net Margins-99.23% Pretax Margin-112.14% Return on Equity-26.70% Return on Assets-22.29% Debt Debt-to-Equity RatioN/A Current Ratio6.58 Quick Ratio6.15 Sales & Book Value Annual Sales$203.57 million Price / Sales6.60 Cash FlowN/A Price / Cash FlowN/A Book Value$14.01 per share Price / Book1.69Miscellaneous Outstanding Shares56,650,000Free Float49,961,000Market Cap$1.34 billion OptionableNot Optionable Beta1.15 Key ExecutivesEmily Marine LeproustChairman & Chief Executive OfficerPatrick J. FinnPresident & Chief Operating OfficerJames M. ThorburnChief Financial OfficerSiyuan ChenChief Technology OfficerNimisha SrivastavaSenior Vice President-Research & DevelopmentKey CompetitorsRecursion PharmaceuticalsNASDAQ:RXRXImmunityBioNASDAQ:IBRXArcellxNASDAQ:ACLXReplimune GroupNASDAQ:REPLAdaptive BiotechnologiesNASDAQ:ADPTView All CompetitorsInsiders & InstitutionsBanque Pictet & Cie SABought 1,294 shares on 2/6/2023Ownership: 0.159%Los Angeles Capital Management LLCSold 3,149 shares on 2/6/2023Ownership: 0.020%Fisher Asset Management LLCBought 234,358 shares on 2/3/2023Ownership: 1.425%D.A. Davidson & CO.Sold 1,575 shares on 2/3/2023Ownership: 0.024%ProShare Advisors LLCBought 972 shares on 2/2/2023Ownership: 0.021%View All Insider TransactionsView All Institutional Transactions TWST Stock - Frequently Asked Questions Should I buy or sell Twist Bioscience stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TWST shares. View TWST analyst ratings or view top-rated stocks. What is Twist Bioscience's stock price forecast for 2023? 6 equities research analysts have issued 1-year target prices for Twist Bioscience's shares. Their TWST share price forecasts range from $29.00 to $43.00. On average, they predict the company's share price to reach $33.83 in the next twelve months. This suggests a possible upside of 41.2% from the stock's current price. View analysts price targets for TWST or view top-rated stocks among Wall Street analysts. How have TWST shares performed in 2023? Twist Bioscience's stock was trading at $23.81 at the beginning of the year. Since then, TWST shares have increased by 0.6% and is now trading at $23.96. View the best growth stocks for 2023 here. When is Twist Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023. View our TWST earnings forecast. How were Twist Bioscience's earnings last quarter? Twist Bioscience Co. (NASDAQ:TWST) released its quarterly earnings data on Friday, February, 3rd. The company reported ($0.74) earnings per share for the quarter, topping the consensus estimate of ($1.09) by $0.35. The business had revenue of $54.20 million for the quarter, compared to analysts' expectations of $54.47 million. Twist Bioscience had a negative net margin of 99.23% and a negative trailing twelve-month return on equity of 26.70%. The company's revenue for the quarter was up 29.0% on a year-over-year basis. During the same period in the prior year, the company posted ($0.91) EPS. What guidance has Twist Bioscience issued on next quarter's earnings? Twist Bioscience updated its FY 2023 earnings guidance on Monday, February, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $261.00 million-$269.00 million, compared to the consensus revenue estimate of $265.53 million. What is Emily Leproust's approval rating as Twist Bioscience's CEO? 44 employees have rated Twist Bioscience Chief Executive Officer Emily Leproust on Glassdoor.com. Emily Leproust has an approval rating of 83% among the company's employees. What other stocks do shareholders of Twist Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Twist Bioscience investors own include CrowdStrike (CRWD), Pfizer (PFE), DocuSign (DOCU), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), JD.com (JD), Tesla (TSLA) and Twilio (TWLO). When did Twist Bioscience IPO? (TWST) raised $75 million in an IPO on Wednesday, October 31st 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Cowen acted as the underwriters for the IPO and Allen & Company and Baird were co-managers. What is Twist Bioscience's stock symbol? Twist Bioscience trades on the NASDAQ under the ticker symbol "TWST." Who are Twist Bioscience's major shareholders? Twist Bioscience's stock is owned by a variety of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (11.83%), Sumitomo Mitsui Trust Holdings Inc. (5.18%), Baillie Gifford & Co. (1.92%), Fisher Asset Management LLC (1.43%), State of New Jersey Common Pension Fund D (0.16%) and Banque Pictet & Cie SA (0.16%). Insiders that own company stock include Emily M Leproust, Emily M Leproust, James M Thorburn, Jan Johannessen, John P Molloy, Keith Crandell, Mark Daniels, Nicolas Barthelemy, Patrick John Finn, Patrick Weiss, Paula Green, Robert Chess and William Banyai. View institutional ownership trends. How do I buy shares of Twist Bioscience? Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Twist Bioscience's stock price today? One share of TWST stock can currently be purchased for approximately $23.96. How much money does Twist Bioscience make? Twist Bioscience (NASDAQ:TWST) has a market capitalization of $1.36 billion and generates $203.57 million in revenue each year. The company earns $-217,860,000.00 in net income (profit) each year or ($3.86) on an earnings per share basis. How many employees does Twist Bioscience have? The company employs 652 workers across the globe. How can I contact Twist Bioscience? Twist Bioscience's mailing address is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.twistbioscience.com. The company can be reached via phone at (800) 719-0671 or via email at maeve@argotpartners.com. This page (NASDAQ:TWST) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.